Dissecting the molecular pathways of primary aldosteronism

Pathology International

Volumn 64, Issue 10, 2014, Pages 482-489

  Nakamura, Yasuhiro ^a   Felizola, Saulo J A ^a   Satoh, Fumitoshi ^b   Konosu Fukaya, Sachiko ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Ca2+ signaling pathway; G protein coupled receptor; Primary aldosteronism; Somatic mutation; Steroidogenic enzymes

Indexed keywords

ALDOSTERONE; CALCIUM; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; MONOCLONAL ANTIBODY;

ALDOSTERONE RELEASE; ARTICLE; CALCIUM SIGNALING; HISTOPATHOLOGY; HORMONE SYNTHESIS; HUMAN; PATHOPHYSIOLOGY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; STEROIDOGENESIS; ANIMAL; GENETICS; HYPERALDOSTERONISM; METABOLISM; MUTATION; SIGNAL TRANSDUCTION;

ALDOSTERONE; ANIMALS; HUMANS; HYPERALDOSTERONISM; ION CHANNELS; MUTATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84937511257     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12200     Document Type: Article

References (50)

1. Milliez P, Girerd X, Plouin PF etal. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243-1248.
2. Sasano H, Nakamura Y, Moriya T etal. Adrenal Cortex. Endocrine Pathology-Differential Diagnosis and Molecular Advances, 2nd edn. New York: Springer, 2009; 211-226.
3. Neville AM, Symington T. Pathology of primary aldosteronism. Cancer 1966; 19: 1854-1868.
4. Lack EE. Tumors of the Adrenal Glands and Extraadrenal Paraganglia, Armed Forces Institute of Pathology Atlas of Tumor Pathology Series 4. Washington: Armed Forces Institute of Pathology, 2007; 116-119.
5. Nakamura Y, Kurotaki Y, Ise K etal. GATA6, SF1, NGFIB and DAX1 in the remodeled subcapsular zones in primary aldosteronism. Endocr J 2014; 61: 393-401.
6. Gomez-Sanchez CE, Qi X, Velarde-Miranda C etal. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol 2014; 383: 111-117.
7. Nakamura Y, Maekawa T, Felizola SJ etal. Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies. Mol Cell Endocrinol 2014; 392: 73-79.
8. Sasano H. Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocrine J 1994; 41: 471-482.
9. Häggström M, Richfield D. Diagram of the pathways of human steroidogenesis. Wikiversity J Med 2014. doi:10.15347/wjm/2014.005.
10. Bassett MH, White PC, Rainey WE. The regulation of aldosterone synthase expression. Mol Cell Endocrinol 2004; 217: 67-74.
11. Cherradi N, Brandenburger Y, Capponi AM. Mitochondrial regulation of mineralocorticoid biosynthesis by calcium and the StAR protein. Eur J Endocrinol 1998; 139: 249-256.
12. Bassett MH, Mayhew B, Rehman K etal. Expression profiles for steroidogenic enzymes in adrenocortical disease. J Clin Endocrinol Metab 2005; 90: 5446-5455.
13. Wu KD, Chen YM, Chu JS etal. Zona fasciculata-like cells determine the response of plasma aldosterone to metoclopramide and aldosterone synthase messenger ribonucleic acid level in aldosterone-producing adenoma. J Clin Endocrinol Metab 1995; 80: 783-789.
14. Rainey WE. Adrenal zonation: clues from 11beta-hydroxylase and aldosterone synthase. Mol Cell Endocrinol 1999; 151: 151-160.
15. Curnow KM, Tusie-Lunaf MT, Pascoe L etal. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocr 1991; 5: 1513-1522.
16. Simard J, Ricketts ML, Gingras S etal. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocrine Rev 2005; 26: 525-582.
17. Doi M, Takahashi Y, Komatsu R etal. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2010; 16: 67-74.
18. Doi M, Satoh F, Maekawa T etal. Isoform-specific monoclonal antibodies against 3beta-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism. J Clin Endocrinol Metab 2014; 99: E257-262.
19. Nogueira EF, Rainey WE. Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology 2010; 151: 1060-1070.
20. Ye P, Mariniello B, Mantero F, Shibata H, Rainey WE. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J Endocrinol 2007; 195: 39-48.
21. Chakraborty P. G-protein-mediated signaling and its control in macrophages and mammalian cells. Crit Rev Microbiol 2001; 27: 1-8.
22. Lefebvre H, Cartier D, Duparc C etal. Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies. J Clin Endocrinol Metab 2002; 87: 1211-1216.
23. Felizola SJA, Nakamura Y, Ono Y etal. PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues. J Mol Endocrinol 2014; 52: 159-167.
24. Nogueira EF, Xing Y, Morris CA, Rainey WE. Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. J Mol Endocrinol 2009; 42: 319-330.
25. Chen YC, Chen Y, Huang SH, Wang SM. Protein kinase Cμ mediates adenosine-stimulated steroidogenesis in primary rat adrenal cells. FEBS Lett 2010; 584: 4442-4448.
26. Felizola SJA, Nakamura Y, Satoh F etal. Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway. Mol Cell Endocrinol 2014; 382: 170-177.
27. Contesse V, Lenglet S, Grumolato L etal. Pharmacological and molecular characterization of 5-hydroxytryptamine (7) receptors in the rat adrenal gland. Mol Pharmacol 1999; 56: 552-561.
28. Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M. Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms. Clin Endocrinol (Oxf) 2001; 54: 627-632.
29. Cartier D, Jégou S, Parmentier F etal. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. Eur J Endocrinol 2005; 153: 939-947.
30. Saner-Amigh K, Mayhew BA, Mantero F etal. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J Clin Endocrinol Metab 2006; 91: 1136-1142.
31. Hurowitz EH, Melnyk JM, Chen YJ, Kouros-Mehr H, Simon MI, Shizuya H. Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes. DNA Res 2000; 7: 111-120.
32. Hille B. G protein-coupled receptor. Scholarpedia 2009; 4: 8214.
33. Liu F, Usui I, Evans LG, Austin DA etal. Involvement of both G(q/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells. J Biol Chem 2002; 277: 32099-32108.
34. Saraví FD, Cincunegui LM, Saldeña TA, Carra GE, Ibáñez JE. Increased oxygen consumption caused by cAMP- and Ca(2+)-mediated chloride secretion in rat distal colon. Acta Gastroenterol Latinoam 2005; 35: 13-18.
35. Zwermann O, Suttmann Y, Bidlingmaier M, Beuschlein F, Reincke M. Screening for membrane hormone receptor expression in primary aldosteronism. Eur J Endocrinol 2009; 160: 443-451.
36. Clem BF, Hudson EA, Clark BJ. Cyclic adenosine 3′, 5′-monophosphate (cAMP) enhances cAMP-responsive element binding (CREB) protein phosphorylation and phospho-CREB interaction with the mouse steroidogenic acute regulatory protein gene promoter. Endocrinology 2005; 146: 1348-1356.
37. Clark BJ, Combs R. Angiotensin II and cyclic adenosine 3′, 5′-monophosphate induce human steroidogenic acute regulatory protein transcription through a common steroidogenic factor-1 element. Endocrinology 1999; 140: 4390-4398.
38. Arora KK, Krsmanovic LZ, Mores N, O'Farrell H, Catt KJ. Mediation of cyclic AMP signaling by the first intracellular loop of the gonadotropin-releasing hormone receptor. J Biol Chem 1998; 273: 25581-25586.
39. Rorick-Kehn LM, Johnson BG, Burkey JL etal. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R, 4S, 5S, 6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4, 6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther 2007; 321: 308-317.
40. Schoepp DD, Johnson BG, Wright RA etal. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology 1997; 36: 1-11.
41. Romero DG, Plonczynski MW, Gomez-Sanchez EP, Yanes LL, Gomez-Sanchez CE. RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells. Endocrinology 2007; 147: 3889-3897.
42. Condon JC, Pezzi V, Drummond BM, Yin S, Rainey WE. Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 2002; 143: 3651-3657.
43. Choi M, Scholl UI, Yue P etal. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011; 331: 768-772.
44. Kleerekoper QK, Putkey JA. PEP-19, an intrinsically disordered regulator of calmodulin signaling. J Biol Chem 2009; 284: 7455-7464.
45. Deisseroth K, Heist EK, Tsien RW. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 1998; 392: 198-202.
46. Wei P, Blundon JA, Rong Y, Zakharenko SS, Morgan JI. Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/pcp4-null mice. Mol Cell Biol 2011; 31: 2838-2844.
47. Akizuki O, Inayoshi A, Kitayama T etal. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R. Eur J Pharmacol 2008; 584: 424-434.
48. Hu C, Rusin CG, Tan Z, Guagliardo NA, Barrett PQ. Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J Clin Invest 2012; 122: 2046-2053.
49. Scholl UI, Goh G, Stölting G etal. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 2013; 45: 1050-1054.
50. Beuschlein F, Boulkroun S, Osswald A etal. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 2013; 45: 440-444.